Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human |
Host species | Mouse |
Applications | ELISA,WB-Re |
Brand: | Abnova |
Reference: | MAB1057 |
Product name: | NCR2 monoclonal antibody, clone 8F12 |
Product description: | Mouse monoclonal antibody raised against partial recombinant NCR2. |
Clone: | 8F12 |
Isotype: | IgG3, kappa |
Gene id: | 9436 |
Gene name: | NCR2 |
Gene alias: | CD336|LY95|NK-p44|NKP44|dJ149M18.1 |
Gene description: | natural cytotoxicity triggering receptor 2 |
Genbank accession: | NM_004828 |
Immunogen: | Recombinant protein corresponding to amino acids 19-130 of human NCR2. |
Protein accession: | NP_004819 |
Form: | Liquid |
Recommend dilutions: | Western Blot (1:1000-1:2000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Mouse |
Antigen species / target species: | Human |
Specificity: | This antibody is specific to NCR2 and does not cross react with NCR3 and NCR1. |
Reactivity: | Human |
Application image: | ![]() |
Application image note: | Western blot analysis of human recombinant proteins NCR3 (Lane 1) , NCR2 (Lane 2) , and NCR1 (Lane 3) (each 20 ng per well) were resolved by SDS - PAGE , transferred to PVDF membrane and probed with NCR2 monoclonal antibody , clone 8F12 (Cat # MAB1057) (1 : 1000) . Proteins were visualized using a goat anti - mouse secondary antibody conjugated to HRP and an ECL detection system. Arrow indicates human recombinant protein NCR2 (residues 19 ~ 130) . |
Applications: | ELISA,WB-Re |
Shipping condition: | Dry Ice |
Publications: | Human natural killer cell receptors: insights into their molecular function and structure.Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, Moretta L, Dimasi N. J Cell Mol Med. 2003 Oct-Dec;7(4):376-87. |